Today: 20 May 2026
Lloyds Bank launches £1.75bn buyback after profit beat, even as motor finance bill swells
29 January 2026
2 mins read

Lloyds Bank launches £1.75bn buyback after profit beat, even as motor finance bill swells

London, Jan 29, 2026, 08:19 GMT

  • Lloyds reported a 12% jump in profit before tax for 2025, hitting £6.7 billion—beating estimates.
  • The bank revealed a share buyback plan worth up to £1.75 billion, pushing total capital returns for 2025 to roughly £3.9 billion.
  • The lender’s motor finance provision now stands at £1.95 billion, as it lifts key targets for 2026.

Lloyds Banking Group kicked off a £1.75 billion ($2.42 billion) share buyback Thursday, following a 2025 profit that topped analyst expectations. The bank also raised its profitability target for 2026. “Our continued business momentum and strategic delivery enable us to upgrade guidance,” CEO Charlie Nunn said, noting the bank will reveal its next strategy phase in July. Reuters

UK bank earnings season starts with this update, giving an early glimpse into whether lenders can maintain dividend payouts amid falling interest rates. Lloyds, the country’s largest mortgage lender, has also emerged as a key indicator of the sector’s handling of rising motor finance compensation risks.

Profit before tax hit £6.7 billion, beating the £6.4 billion consensus, with the bank raising its 2026 targets for return on tangible equity and net interest income, Sharecast reported. Return on tangible equity (RoTE) gauges profit relative to shareholders’ tangible capital, while net interest income reflects what a bank earns from loans after covering interest on deposits and funding.

Lloyds set aside £968 million for remediation costs in 2025—funds earmarked to compensate customers—The Independent reported. Included in that figure was an £800 million charge linked to motor finance commission arrangements. The bank’s total bill for the issue has now hit £1.95 billion.

Net interest income climbed 6% to £13.6 billion, according to figures shared in a regulatory release posted on CentralCharts. The banking net interest margin edged higher to 3.06%. This margin represents net interest income divided by interest-earning assets.

On its investor page, Lloyds reported a net income of £18.30 billion and operating costs tallying £9.76 billion for 2025. Statutory profit after tax came in at £4.76 billion. “This enables total shareholder distributions of c.£3.9 billion for the year,” Nunn said in the update. Lloyds Banking Group

In its full-year report, the bank set a target cost:income ratio under 50% by 2026 — that’s costs as a percentage of income — and an asset quality ratio near 25 basis points, or about 0.25% of lending, which serves as a rough gauge for credit losses. It added that it will reassess excess capital distributions alongside the regular dividend twice a year.

Lloyds reported that its strategic initiatives are expected to generate £1.4 billion in annualised additional revenues by 2025, and it now aims for around £2 billion by the end of 2026, surpassing its previous target. The bank also highlighted £1.9 billion in gross cost savings since 2021, driven by investments in digital and AI technologies.

The Financial Times highlighted Lloyds’ focus on expanding its smaller business segments as a key factor behind the improved earnings.

The motor finance problem isn’t going away anytime soon. Back in December, the Financial Conduct Authority put the cost of a proposed compensation scheme at around £11 billion. But some in the industry reckon the real number could be closer to £18-20 billion. Barclays and Close Brothers have already ramped up their provisions. Adrian Dally, motor finance director at the Finance and Leasing Association, cautioned that for the redress plan to hold water, it must compensate only those customers who actually suffered a loss.

Lloyds posted a RoTE of 12.9% for 2025, rising to 14.8% after excluding the third-quarter motor finance charge, Investing.com reported. The fourth quarter came in at 15.7%, according to the report. Nunn said the bank plans to share more details on the next phase of its strategy in July.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move
Previous Story

HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move

Sage stock hits one-year low as SGE.L slides again, with broker cut and buyback in play
Next Story

Sage stock hits one-year low as SGE.L slides again, with broker cut and buyback in play

Go toTop